JPMorgan Downgrades Teva Pharma (TEVA) to Neutral
Tweet Send to a Friend
JPMorgan downgraded Teva Pharma (NYSE: TEVA) from Overweight to Neutral with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
